Curaleaf (OTCMKTS:CURLF) Downgraded by Cormark to “Hold”

Curaleaf (OTCMKTS:CURLF) was downgraded by Cormark from a “moderate buy” rating to a “hold” rating in a research report issued on Thursday,Zacks.com reports.

Separately, Needham & Company LLC reissued a “buy” rating and set a $6.25 price objective on shares of Curaleaf in a report on Thursday, August 8th.

Curaleaf Stock Up 3.6 %

Shares of OTCMKTS CURLF opened at $2.25 on Thursday. The stock has a market cap of $1.46 billion, a PE ratio of -6.44 and a beta of 0.86. The business has a fifty day moving average of $2.99 and a two-hundred day moving average of $3.82. Curaleaf has a 52-week low of $2.07 and a 52-week high of $6.40. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.50 and a current ratio of 1.09.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01). The company had revenue of $342.29 million for the quarter, compared to the consensus estimate of $344.57 million. Curaleaf had a negative net margin of 18.59% and a negative return on equity of 14.75%. As a group, equities research analysts expect that Curaleaf will post -0.24 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.